Alzheimer and TB006

A potentially revolutionary Alzheimer's treatment as demonstrated by a heart touching story (more)

  • Safety is our highest priority

    At Truebinding we make sure every precaution is taken to ensure the safety of you and your loved ones. To date, TB006 has been safe and well tolerated by study participants .

  • A New Type of Treatment

    We believe that everyone has the right to live a full and happy life unburdened by mental illness, and it’s why we’re working so hard to develop an effective treatment, and with your help, we can.

  • We Make Participation Easy

    Being a caregiver is hard, we at Truebinding recognize that. It’s why we take every avenue possible to cater to you and your loved ones. Truebinding’s clinical trial is only for one month.

 FAQs

  • Currently our clinical trial age limit is between 50-90 years old.

  • Our upcoming trial will be 12 month long. If you are interested, please fill out the contact form.

  • Hypertension and diabetes are inclusive within our clinical trial.

  • While most trials exclude patients with cerebrovascular diseases, at Truebinding we do our best to make sure they are included. As long as the dementia is not caused by cerebrovascular disease they should be included.

  • Yes, per FDA’s new definition, you need to be plaque positive to qualify as a Alzheimer’s patient, so we will follow the FDA guidance in this upcoming trial.

Have a question not covered above? Fill out the form below to get in touch with one of our knowledgeable representatives.

Get in touch.

If you have any questions, or you’re ready to sign up, fill out the form below and one of our clinical site support specialists will contact you. Help us free the world from Alzheimer’s and Acute Ischemic stroke. Together we’ll create a better, longer life for everyone.